Harold Richter
Medical Oncology · Delray Beach, FLNPI 1790733053
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Novartis at 28.4% of the total. Reporting peaked in 2019 at $127 and has fallen 67.4% since, to $41 in 2024. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 15 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$69
- Johnson & Johnson$27
- Aurobindo Pharma USA, Inc.$26
- Daiichi Sankyo Inc.$25
- Karyopharm Therapeutics Inc.$22
- Beigene USA, Inc.$19
- plus $54 from 4 others
Across 31 payments — averaging $19,064 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$543K
- AstraZeneca$27K
- EMD Serono, Inc.$13K
- Novocure GmbH$7K
- Acerta Pharma LLC$455
What the payments were for
- Food & beverage$23196%
- Education$114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $69 |
| Johnson & Johnson | 2 | $27 |
| Aurobindo Pharma USA, Inc. | 2 | $26 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Karyopharm Therapeutics Inc. | 1 | $22 |
| Beigene USA, Inc. | 1 | $19 |
| Sanofi | 1 | $15 |
| Pfizer | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Merck | 1 | $11 |
How this compares
$242 in reported general payments places this provider in the 5th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Delray Beach
- Warren BrennerDelray Beach$99K
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.